Milestone Pharmaceuticals Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $112.6M | $114.1M |
| FY2022 | — | $66.3M | $7.6M |
| FY2023 | $49.8M | $16.8M | $13.8M |
| FY2024 | $53.4M | $13.1M | $25.3M |
| FY2025 | $57.2M | $41.8M | $73.0M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $112.6M | $114.1M |
| FY2022 | — | $66.3M | $7.6M |
| FY2023 | $49.8M | $16.8M | $13.8M |
| FY2024 | $53.4M | $13.1M | $25.3M |
| FY2025 | $57.2M | $41.8M | $73.0M |